[Türkçe]

Turkish Society of Cardiology Young Cardiologists Bulletin Year: 5 Number: 6 / 2022


Turkish Society of Cardiology
Young Cardiologists
President
Dr. Muzaffer Değertekin

Coordinator for the
Board of Directors

Dr. Ertuğrul Okuyan

Coordinator for the
Board of Directors

Dr. Can Yücel Karabay

Members
Dr. Adem Aktan
Dr. Gülşah Aktüre
Dr. Bayram Arslan
Dr. İnanç Artaç
Dr. Ahmet Oğuz Aslan
Dr. Görkem Ayhan
Dr. Ahmet Anıl Başkurt
Dr. Özkan Bekler
Dr. Oğuzhan Birdal
Dr. Yusuf Bozkurt Şahin
Dr. Serkan Bulgurluoğlu
Dr. Ümit Bulut
Dr. Veysi Can
Dr. Mustafa Candemir
Dr. Murat Çap
Dr. Göksel Çinier
Dr. Ali Çoner
Dr. Yusuf Demir
Dr. Ömer Furkan Demir
Dr. Murat Demirci
Dr. Ayşe İrem Demirtola Mammadli
Dr. Süleyman Çağan Efe
Dr. Mehmet Akif Erdöl
Dr. Kubilay Erselcan
Dr. Kerim Esenboğa
Dr. Duygu Genç
Dr. Kemal Göçer
Dr. Elif Güçlü
Dr. Arda Güler
Dr. Duygu İnan
Dr. Hasan Burak İşleyen
Dr. Muzaffer Kahyaoğlu
Dr. Sedat Kalkan
Dr. Yücel Kanal
Dr. Özkan Karaca
Dr. Ahmet Karaduman
Dr. Mustafa Karanfil
Dr. Ayhan Kol
Dr. Fatma Köksal
Dr. Mevlüt Serdar Kuyumcu
Dr. Yunus Emre Özbebek
Dr. Ahmet Özderya
Dr. Yasin Özen
Dr. Ayşenur Özkaya İbiş
Dr. Çağlar Özmen
Dr. Selvi Öztaş
Dr. Hasan Sarı
Dr. Serkan Sivri
Dr. Ali Uğur Soysal
Dr. Hüseyin Tezcan
Dr. Nazlı Turan
Dr. Berat Uğuz
Dr. Örsan Deniz Urgun
Dr. İdris Yakut
Dr. Mustafa Yenerçağ
Dr. Mehmet Fatih Yılmaz
Dr. Yakup Yiğit
Dr. Mehmet Murat Yiğitbaşı

Bulletin Editors
Dr. Muzaffer Değertekin
Dr. Bülent Mutlu
Dr. Süleyman Çağan Efe
Dr. Göksel Çinier
Dr. Duygu İnan
Dr. Sedat Kalkan

Contributors
Dr. Onur Akhan
Dr. Fatih Aksoy
Dr. Derya Baykiz
Dr.  İlyas Çetin
Dr. Uğur Ozan Demirhan
Dr. Elif Ayduk Gövdeli
Dr. Mustafa Ferhat Keten
Dr. Bengisu Keskin Meriç
Dr. İbrahim Halil Özdemir
Dr. Mehmet Arslan
Dr. Hüseyin Durak
Dr. Levent Pay


 



6--14

Safety and Efficacy Study of artificial intelligence (AI) LVEF (EchoNet-RCT)Türk Kardiyoloji Derneği Genç Kardiyologlar Bülteni - Safety and Efficacy Study of artificial intelligence (AI) LVEF (EchoNet-RCT) (Dr. Bengisu Keskin Meriç)

Reviewer: Dr. Bengisu Keskin Meriç

Name of the Study: Safety and Efficacy Study of artificial intelligence (AI) LVEF (EchoNet-RCT)

Published Congress: ESC 2022

Background:

Although there has been great progress in the application of artificial intelligence (AI) to the field of cardiology, there are no randomized controlled studies yet.

Objective:

The aim of this study is to determine whether an integrated artificial intelligence program can save time and improve the accuracy of evaluation of echocardiograms.

Methods:

Researchers; designed a blinded, randomized controlled trial to compare left ventricular ejection fraction in the initial evaluation of echocardiograms with sonographer versus AI-guided measures. Echocardiograms were randomized 1:1 to either the sonographer's pre-interpretation finding or the AI pre-interpretation finding, based on the final decision made by the cardiologist. In the study, it was evaluated how much the preliminary interpretation was edited and changed by the cardiologists from the first interpretation. Primary outcomes was considered; the proportion of studies in which the LVEF was modified by more than 5% in the final report and the mean change in LVEF.

Results:

3495 patients were randomized into the study. Cardiologists could not distinguish between the initial assessments of AI and sonographers [ (Correct 32.3%), (Unsure 43.4%), (Incorrect 24.2) bangs dazzling index: 0.088 ]. Significant change between both reports; 292 (16.8%) in the AI arm and 478 (27.2%) in the sonography design arm (difference -10.4%, 95%CI -13.2% to -7.7, p<0.001). The mean absolute difference was 2.79±5.53 in the AI arm and 3.77±5.22 in the sonographer arm (difference -0.97, CI 95% -1.31 to -0.61, p<0.001). The safety endpoint was the difference between the final cardiologist report and a historical cardiologist report. The mean absolute difference was 6.29% in the AI group and 7.23% in the sonographer group (difference -0.96%, 95% CI -1.34% to -0.54%, p<0.001 for superiority). Results from subgroups based on patient characteristics, imaging study characteristics and cardiologist prediction were consistent with the overall study results.

Conclusion:

In adult patients undergoing echocardiographic assessment of cardiac function, the preliminary assessment of LVEF by AI was superior to that of the sonographer and more consistent with the previous assessment of the cardiologist.

Interpretations:

The incorporation of AI into clinical use could potentially lead to earlier detection of clinical deterioration or response to treatment, providing more precise and consistent assessments.


6--14

 2025 © Turkish Society of Cardiology.